Account
Articles
24.01.2024
What are the 5 Pricing & Market Access trends...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Publications
25.10.2023
ISPOR Europe 2023: Evaluation and Reimbursement of...

Our study compares and contrasts the evaluation and reimbursement pathways for digital therapeutics ...

Read more
Articles
01.06.2023
Digital health applications in EU5 market access

We explore the rapidly evolving market access landscape in respect to digital health applications in...

Read more
News
17.05.2023
PMA Insights: Week 20 SPECIAL EDITION – ISPO...

We summarise ISPOR Annual 2023 including plenary sessions on artificial intelligence, real-world evi...

Read more
Case Studies
26.04.2023
Our client wanted to gain an understanding

Our client wanted to gain an understanding of payer willingness to pay and determine the likely clin...

Read more
Publications
21.04.2023
ISPOR US 2023: How do the reimbursement opportunit...

Our research compares and contrasts the reimbursement landscapes of digital health applications (DHA...

Read more
Articles
24.08.2022
Healthcare apps and devices in the UK: Who picks u...

Digital therapeutics: a growing market The year is 2008 and Apple have just added a new category to ...

Read more
Articles
23.08.2022
How was the first digital therapeutic Sleepio asse...

Introduction Digital therapeutics (DTx) or digital health technologies (DHTs) are defined as product...

Read more
News
27.07.2022
PMA Insights Week 30

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
27.07.2022
Macmillan alliance will provide digital health app

According to Big health, randomised controlled trials have shown that 71% of patients who used Dayli...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.